Pfizer Ltd., specializes in Pharmaceuticals within the Healthcare sector.
Pfizer Ltd.,, with Security Code 500680, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 5,466.30 | 1,788.60 | 6,217.60 | 22.33 | -927.50 | 751.30 | -137.50 | 2,438.60 |
2023-10-01 | 2023-12-31 | 5,399.70 | 1,299.80 | 5,758.20 | 27.12 | -1,154.90 | 358.50 | -175.50 | 1,759.40 |
2023-07-01 | 2023-09-30 | 5,752.10 | 1,489.60 | 6,112.80 | 32.56 | -980.30 | 360.70 | -154.30 | 2,005.20 |
2023-04-01 | 2023-06-30 | 5,313.60 | 935.30 | 5,648.20 | 20.44 | -1,112.30 | 334.60 | -155.50 | 1,257.50 |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 1% |
3 Years: | -1% |
TTM: | -10% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | 5% |
3 Years: | 3% |
TTM: | -9% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 6% |
3 Years: | -7% |
1 Year: | 22% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 6% |
3 Years: | -7% |
1 Year: | 22% |
The results of a clinical trial involving over 2,200 children showed that the vaccine was 90.7% effective in preventing symptomatic COVID-19 in this age group.
The companies announced that they have submitted data to the FDA showing that their updated boosters provide a strong immune response against the Omicron variant.
The company reported revenue of $81.3 billion for the year, up 92% from 2020. Net income was $21.9 billion, up 103% from 2020.